Biotech

All Articles

8 months after a $213M fundraise, gene editor Volume produces reduces

.After raising $213 million in 2023-- some of the year's biggest private biotech shots-- Tome Biosci...

BioMarin builds director team with biotech veterinarians-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable leadership hirings, shootings an...

Biopharma Q2 VC hit highest level because '22, while M&ampA reduced

.Financial backing financing into biopharma cheered $9.2 billion across 215 handle the 2nd quarter o...

Bicara, Zenas seek IPOs to press late-phase possessions toward market

.Bicara Therapeutics and also Zenas Biopharma have actually offered new impetus to the IPO market wi...

Genentech to close cancer cells immunology research team

.Genentech will certainly shut its own cancer immunology research division, as well as device head a...

Kezar goes down sound tumor yet to verify its own worth in phase 1 test

.Kezar Life Sciences is falling its dim stage 1 solid lump medicine as the biotech goes all-in on it...

Acelyrin falls izokibep, dismisses 3rd of personnel

.Regardless of izokibep keeping its newly found winning touch in the clinic, Acelyrin is no more pay...

Rivus' period 2 obesity-related cardiac arrest trial hits endpoint

.Rivus Pharmaceuticals has actually plumped up the leads of its fat-busting, muscle-sparing drug app...

Ovid stops preclinical work, IV system after soticlestat stop working

.Ovid Therapeutics currently exposed last month that it was trimming back its head count as the prov...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has actually opened up a $700 million R&ampD center in the Boston Port, boosting its RNA ...